Content about Sleep disorders

March 5, 2013
P&G co-promotes sleep with Downy and ZzzQuill for National Sleep Awareness Week

Procter & Gamble’s Downy and ZzzQuil brands have joined forces to help consumers create an environment that is conducive for falling asleep in time for National Sleep Awareness Week March 3-10.

February 7, 2013
Purdue Pharma drug 'significantly' reduces time to fall back asleep in insomnia patients, study finds

An insomnia drug made by Purdue Pharma "significantly" reduced the time it took patients to return to sleep after they'd woke up in the middle of the night, according to a new study.

January 10, 2013
FDA calls for lower dosage in some insomnia drugs

The Food and Drug Administration is ordering the makers of several sleep drugs to lower the dosage due to the risk that they can impair patients the morning after, the agency said Thursday.

September 10, 2012
Patients who stop taking insomnia drug continue having sleeping problems, Merck study finds

A study of an experimental drug for insomnia indicated that patients who stop taking it continue having sleeping problems, according to results of a clinical trial announced Monday.

June 21, 2012
New merchandising could waken sleep aids

Retailers are awakening to the possibility that their sleep aids — typically merchandised near the floor level of a set synergistically near tablet pain relievers — may deserve a placement closer to eye level.

June 18, 2012
P&G adds new 'so you can rest' medicine to its portfolio

Procter & Gamble on Monday officially announced the introduction of ZzzQuil, a sleep aid addition to its Vicks NyQuil and Vicks DayQuil brands.

June 14, 2012
Crown Dynamics introduces patented device to help decrease snoring

Crown Dynamics on Wednesday launched its patented Air Sleep/Snore product line.

December 16, 2011
Lyrica produces 'significant' improvement in restless legs syndrome

A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

November 23, 2011
FDA approves first drug for insomnia with middle-of-night waking, difficulty returning to sleep

The Food and Drug Administration has approved the first drug for insomnia in which patients wake in the middle of the night and have trouble returning to sleep.

April 7, 2011
Horizant OKed as restless legs syndrome treatment

The Food and Drug Administration has approved a drug made by GlaxoSmithKline and Xenoport for treating restless legs syndrome, the agency said Thursday.

March 4, 2011
Splintek wants consumers to breathe right with SleepRight

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight Nasal Breathe Aid — a snore-relieving product entry into the nasal strip category that retails for a suggested $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each SleepRight Breathe Aid lasts up to 15 days. 

February 23, 2011
SleepRight adds nasal breathe aids to lineup

Splintek Health Products recently launched its SleepRight nasal breathe aide — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

December 8, 2010
Graymark sets its sights on sleep disorders

Following the sale of ApothecaryRx pharmacies to Walgreens, Graymark Healthcare said it is shifting its focus to sleep disorders, including obstructive sleep apnea.

November 11, 2010
Roadside announces partnership to further 'drive' wellness programs

Two companies have formed a partnership to provide services for long-haul truck drivers....

October 24, 2010
FDA approves REMS for Nuvigil, Provigil

The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep...

September 6, 2010
Silenor now available by prescription

Drug maker Somaxon Pharmaceuticals has made its treatment for insomnia available by prescription, the company...

June 16, 2010
Mid-stage trial results positive for Merck's insomnia drug

An investigational treatment made by Merck for insomnia was more effective than placebo in improving...

May 17, 2010
Sleep apnea may up diabetes risk, study finds

Sleep apnea may cause metabolic changes that increase insulin resistance, according to researchers from the...

January 10, 2010
Mylan confirms first-to-file patent challenge for Nuvigil generic

Drug maker Cephalon and its French subsidiary sued generic drug maker Mylan in connection with...

January 5, 2010
Watson seeks FDA approval for sleep disorder treatment

Watson has filed an abbreviated new drug application for the generic version of a sleep...

© 2013 Drug Store News. All Rights Reserved.